Paul Tran, MD/PhD
Clinical FellowAbout
Titles
Clinical Fellow
Biography
I completed my MD/PhD at Augusta University (Medical College of Georgia) in type 1 diabetes genetics. My career goal is to be an academic pulmonary and critical care physician.
Outside of medicine and research, I enjoy outdoor activities and hanging out with my two- and four-legged family members!
Departments & Organizations
- ABIM Physician-Scientist Research Pathway
- Internal Medicine
Education & Training
- Residency
- Yale New Haven Hospital (2024)
- MD/PhD
- Augusta University, Genomic Medicine (2022)
- BS
- University of North Georgia, Biology and Chemistry (2014)
Research
Overview
During graduate school, my primary mentor was Jin-Xiong She, with co-mentoring from Sharad Purohit and Richard McIndoe. The first half of this experience was focused on transcriptomic classification of brain cancers. This experience taught me the data analysis and coding skills necessary for processing gene expression data. During the second half of graduate school, I pivoted to research in type 1 diabetes, which has been the primary focus of the She lab for more than 20 years. I used data from the Type 1 Diabetes Genetics Consortium (PI: Steve Rich) and serum biomarker data from our local type 1 diabetes cohorts (PAGODA) and that of our collaborators at the University of Colorado Barbara Davis Diabetes Center(DAISY, PI: Marian Rewers) to fine map non-HLA genetic loci associated with type 1 diabetes. This approach allowed us to posit potential mechanisms for these associations with disease. Around 2018, Sharad Purohit and Jin-Xiong She developed a multiplex array for detecting serum anti-carbohydrate antibodies against more than 200 glycan structures (provided by Peng Wang lab and National Consortium for Function Glycomics, PI: Richard Cummings). This platform allowed us to identify a unique set of biomarkers associated with type 1 diabetes and helped generate hypotheses for other environmental factors associated with type 1 diabetes. Many of the carbohydrates in our panel are from foreign sources to humans, including microbial and plant origins. The results from this work are currently under review, but provide an exciting avenue for biomarker discovery and environmental exposure association with immune-related diseases.
Publications
2021
T1DMicro: A Clinical Risk Calculator for Type 1 Diabetes Related Microvascular Complications.
Tran PMH, Kim E, Tran LKH, Khaled BS, Hopkins D, Gardiner M, Bryant J, Bernard R, Morgan J, Bode B, Reed JC, She JX, Purohit S. T1DMicro: A Clinical Risk Calculator for Type 1 Diabetes Related Microvascular Complications. International Journal Of Environmental Research And Public Health 2021, 18 PMID: 34769614, PMCID: PMC8583376, DOI: 10.3390/ijerph182111094.Peer-Reviewed Original ResearchSerum Levels of Inflammatory Proteins Are Associated With Peripheral Neuropathy in a Cross-Sectional Type-1 Diabetes Cohort.
Purohit S, Tran PMH, Tran LKH, Satter KB, He M, Zhi W, Bai S, Hopkins D, Gardiner M, Wakade C, Bryant J, Bernard R, Morgan J, Bode B, Reed JC, She JX. Serum Levels of Inflammatory Proteins Are Associated With Peripheral Neuropathy in a Cross-Sectional Type-1 Diabetes Cohort. Frontiers In Immunology 2021, 12: 654233. PMID: 33868296, PMCID: PMC8044415, DOI: 10.3389/fimmu.2021.654233.Peer-Reviewed Original ResearchThe 3p21.31 genetic locus promotes progression to type 1 diabetes through the CCR2/CCL2 pathway.
Tran PM, Purohit S, Kim E, Bin Satter K, Hopkins D, Waugh K, Dong F, Onengut-Gumuscu S, Rich SS, Rewers M, She JX. The 3p21.31 genetic locus promotes progression to type 1 diabetes through the CCR2/CCL2 pathway. Journal Of Translational Autoimmunity 2021, 4: 100127. PMID: 35005592, PMCID: PMC8716652, DOI: 10.1016/j.jtauto.2021.100127.Peer-Reviewed Original Research
News & Links
News
Related Links